Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cytomegalovirus Infection

  Free Subscription


Articles published in Antimicrob Agents Chemother

Retrieve available abstracts of 20 articles:
HTML format



Single Articles


    December 2020
  1. SU H, Ye X, Freed DC, Li L, et al
    A potent bispecific neutralizing antibody targeting glycoprotein B and the gH/gL/pUL128/130/131 complex of human cytomegalovirus.
    Antimicrob Agents Chemother. 2020 Dec 23. pii: AAC.02422.
    PubMed     Abstract available


    October 2020
  2. HAMILTON ST, Marschall M, Rawlinson WD
    Investigational antiviral therapy models for the prevention and treatment of congenital cytomegalovirus infection during pregnancy.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01627.
    PubMed     Abstract available


    July 2020
  3. MERCORELLI B, Luganini A, Celegato M, Palu G, et al
    The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication.
    Antimicrob Agents Chemother. 2020 Jul 20. pii: AAC.00056.
    PubMed     Abstract available


    February 2020
  4. ZARROUK K, Pham VD, Piret J, Shi R, et al
    Hypersusceptibility of Human Cytomegalovirus to Foscarnet Induced by Mutations in Helices K and P of the Viral DNA Polymerase.
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.01910.
    PubMed     Abstract available


  5. MAERTENS J, Logan AC, Jang J, Long G, et al
    Anti-human cytomegalovirus monoclonal antibodies for prophylaxis in hematopoietic cell transplantation: a phase 2 study.
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.02467.
    PubMed     Abstract available


    May 2019
  6. TURNER NA, Wolfe CR
    Reply to Frange and Leruez-Ville, "Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases".
    Antimicrob Agents Chemother. 2019;63.
    PubMed    


  7. FRANGE P, Leruez-Ville M
    Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases.
    Antimicrob Agents Chemother. 2019;63.
    PubMed    


    March 2019
  8. RITCHIE BM, Barreto JN, Barreto EF, Crow SA, et al
    Relationship of Ganciclovir Therapeutic Drug Monitoring with Clinical Efficacy and Patient Safety.
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Abstract available


    January 2019
  9. TURNER N, Strand A, Grewal DS, Cox G, et al
    Use of Letermovir as Salvage Therapy for Drug-resistant CMV Retinitis: A Case Series.
    Antimicrob Agents Chemother. 2019 Jan 14. pii: AAC.02337.
    PubMed     Abstract available


    October 2018
  10. WANG Y, Mukhopadhyay R, Roy S, Kapoor A, et al
    Inhibition of Cytomegalovirus Replication with Extended Half-Life Synthetic Ozonides.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01735.
    PubMed     Abstract available


    June 2018
  11. CHOU S, Satterwhite LE, Ercolani RJ
    A New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by in vitro Exposure to Letermovir and Ganciclovir.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00922.
    PubMed     Abstract available


    April 2018
  12. OIKNINE-DJIAN E, Weisblum Y, Panet A, Wong HN, et al
    The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00288.
    PubMed     Abstract available


    March 2018
  13. DONG Q, Leroux S, Shi HY, Xu HY, et al
    Model-based Dosage Individualization of Ganciclovir in Neonates and Young Infants with Congenital Cytomegalovirus Infection: A Pilot Study.
    Antimicrob Agents Chemother. 2018 Mar 5. pii: AAC.00075.
    PubMed     Abstract available


    November 2017
  14. DENG R, Wang Y, Maia M, Burgess T, et al
    Pharmacokinetics and exposure-response analysis of RG7667, a combination of two anti-cytomegalovirus monoclonal antibodies, in a Phase 2a randomized trial to prevent cytomegalovirus infection in high-risk kidney transplant recipients.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01108.
    PubMed     Abstract available


    October 2017
  15. MENG W, Tang A, Ye X, Gui X, et al
    Targeting Human Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-gB Bispecific Antibody.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01719.
    PubMed     Abstract available


    August 2017
  16. CHOU S
    Comparison of Cytomegalovirus Terminase Gene Mutations Selected after Exposure to Three Distinct Inhibitor Compounds.
    Antimicrob Agents Chemother. 2017 Aug 21. pii: AAC.01325.
    PubMed     Abstract available


  17. PIRET J, Goyette N, Boivin G
    Drug Susceptibility and Replicative Capacity of Multi-Drug Resistant Recombinant Human Cytomegalovirus Harboring Mutations in UL56 and UL54 Genes.
    Antimicrob Agents Chemother. 2017 Aug 14. pii: AAC.01044.
    PubMed     Abstract available


    November 2016
  18. ISHIDA JH, Patel A, Mehta AK, Gatault P, et al
    Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.
    Antimicrob Agents Chemother. 2016 Nov 21. pii: AAC.01794.
    PubMed     Abstract available


    April 2016
  19. PADULLES A, Colom H, Bestard O, Melilli E, et al
    Contribution of Population Pharmacokinetics to Dose Optimization of Ganciclovir-Valganciclovir in Solid-Organ Transplant Patients.
    Antimicrob Agents Chemother. 2016;60:1992-2002.
    PubMed     Abstract available


    November 2015
  20. VAZQUEZ JA, Manavathu EK
    Molecular Characterization of a Voriconazole-resistant, Posaconazole-susceptible, Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.
    Antimicrob Agents Chemother. 2015 Nov 16. pii: AAC.01130.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cytomegalovirus Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: